MedPath

Lantheus Mi Canada, Inc.

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Perflutren Lipid Microsphere Injection

Product Name
八氟丙烷脂质微球注射液
Approval Number
国药准字HJ20220082
Approval Date
Nov 15, 2022
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath